BrainsWay Ltd.
NASDAQ:BWAYMedical - Devices
Healthcare
$8.73 +0.35%
+$0.05 today
- Market cap
- $342.42M
- Beta
- 0.15
- P/E (TTM)
- 61.7
- EPS (TTM)
- $0.23
52W Low $5.42High $17.35
Volume 0.12M
Average 0.15M
Income Statement
Follow revenue through to earnings.
Revenue
$52.23M
FY 2025 · Annual
+27.3% YoYOperating Income
$4.32M
FY 2025 · Annual
+210.8% YoYNet Income
$7.63M
FY 2025 · Annual
+161.3% YoYIncome Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 29.66M | 27.18M | 31.79M | 41.02M | 52.23M |
| Cost of Revenue | 6.6M | 7.13M | 8.31M | 10.44M | 12.84M |
| Gross Profit | 23.06M | 20.05M | 23.48M | 30.58M | 39.39M |
| Gross Margin | 77.7% | 73.8% | 73.9% | 74.6% | 75.4% |
| Research & Development | 6.39M | 7.68M | 6.67M | 7.19M | 9.6M |
| Selling, General & Admin | 21.66M | 25.05M | 21.64M | 22M | 25.46M |
| Operating Expenses | 28.06M | 32.73M | 28.44M | 29.19M | 35.06M |
| Depreciation & Amortization | 1.69M | 1.53M | 1.34M | 1.77M | 1.54M |
| EBITDA | (4.67M) | (11.45M) | (2.56M) | 5.36M | 11.46M |
| EBITDA Margin | -15.8% | -42.1% | -8.1% | 13.1% | 21.9% |
| Operating Income | (5M) | (12.68M) | (4.96M) | 1.39M | 4.32M |
| Operating Margin | -16.9% | -46.7% | -15.6% | 3.4% | 8.3% |
| Interest Income | 225K | 1.11M | 2.17M | 2.48M | 5.64M |
| Interest Expense | 141K | 68K | 298K | 1.36M | 2.23M |
| Other Income / Expenses | (1.42M) | (351K) | 1.01M | 2.07M | 3.39M |
| Income Before Tax | (6.42M) | (13.03M) | (3.95M) | 3.46M | 7.71M |
| Pre-Tax Margin | -21.6% | -48.0% | -12.4% | 8.4% | 14.8% |
| Income Tax Expense | 43K | 315K | 251K | 538K | 77K |
| Net Income | (6.46M) | (13.35M) | (4.2M) | 2.92M | 7.63M |
| Net Margin | -21.8% | -49.1% | -13.2% | 7.1% | 14.6% |
| EPS (Basic) | (0.21) | (0.43) | (0.13) | 0.09 | 0.40 |
| EPS (Diluted) | (0.21) | (0.43) | (0.13) | 0.09 | 0.36 |
| 31.15M | 32.98M | 33.16M | 33.97M | 19.08M | |
| 31.15M | 32.98M | 33.16M | 34.77M | 21.21M |
BWAY Earnings Waterfall · TTM
NASDAQ:BWAY · Revenue to Net Income
Key Ratios
EPS$0.35
Gross Margin75.5%
Net Margin15.6%
P/E Ratio29.7
P/S Ratio17.3
Analysis
$56.2M of revenue converted into $8.8M of net income for the selected period. Gross margin is 75.5% and net margin is 15.6%, showing how much revenue survives after costs and taxes. EPS is $0.35, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 10, 2026 | |
| 6-K | 6-K filing | Nov 10, 2026 | |
| 6-K | 6-K filing | Nov 2, 2026 | |
| 6-K/A | 6-K/A filing | Oct 26, 2026 | |
| 6-K | 6-K filing | Oct 26, 2026 |
How much revenue does BWAY generate?
BrainsWay Ltd. (BWAY) reported $52.23M of revenue in fiscal 2025.
Is BWAY profitable?
BrainsWay Ltd. (BWAY) reported $7.63M of net income, with a net margin of 14.6%.
Continue the stock analysis
Jump to another research area for this company.